Mark Massaro analyst BTIG

Currently out of the existing stock ratings of Mark Massaro, 35 are a HOLD (14.06%), 207 are a BUY (83.13%), 7 are a SELL (2.81%).

Mark Massaro

Work Performance Price Targets & Ratings Chart

Analyst Mark Massaro works at BTIG with a stock forecast success ratio of 48.47% fulfilled within 137.18 days on average. Previously, Mark Massaro worked at CANACCORD.

Mark Massaro’s has documented 493 price targets and ratings displayed on 39 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on NEO, NeoGenomics at 29-Dec-2023.

Wall Street Analyst Mark Massaro

Analyst best performing recommendations are on HTGM (HTG MOLECULAR DIAGNOSTICS).
The best stock recommendation documented was for HTGM (HTG MOLECULAR DIAGNOSTICS) at 6/2/2015. The price target of $3060 was fulfilled within 1 day with a profit of $151.2 (5.2%) receiving and performance score of 51.98.

Average potential price target upside

ADPT Adaptive Biotechnologies Corp BLI Berkeley Lights  DGX Quest Diagnostics orporated EXAS EXACT Sciences GH Guardant Health GHDX Genomic Health HOLX Hologic HSKA Heska HTGM HTG Molecular Diagnostics IDXX IDEXX Laboratories LH Laboratory of America Holdings NTRA Natera OCX OncoCyte Corp OSUR OraSure Technologies QDEL Quidel QTNT Quotient Ltd RNLX Renalytix AI TTOO T2 Biosystms DNA Ginkgo Bioworks Holdings ILMN Illumina LUCD Lucid Diagnostics NEO NeoGenomics PSNL Personalis TLIS Talis Biomedical Corp VIVO Meridian Bioscience DMTK DermTech HLTH Cue Health LMDX LumiraDx Ltd MXCT MaxCyte SMFR Sema4 Holdings Corp XGN Exagen CDNA Caredx GNMK GenMark Diagnostics AKYA Akoya Biosciences CEMI Chembio Diagnostics CSTL Castle Biosciences MDXH MDxHealth SA ADR BNGO Bionano Genomics CERS Cerus

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$1.18 (30.89%)

7 days ago

1/3 (33.33%)

$1.04 (26.26%)




$9.18 (240.31%)


3 months 10 days ago

4/8 (50%)

$9.54 (275.72%)




$6.18 (161.78%)


3 months 30 days ago

1/6 (16.67%)

$5.31 (113.22%)




$3.18 (83.25%)


1 years 8 days ago

2/2 (100%)

$-3.03 (-30.21%)




$9.55 (175.23%)

1 years 1 months 18 days ago

0/1 (0%)

$6.92 (85.64%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Mark Massaro is most bullish on?

Potential upside of $13.85 has been obtained for NTRA (NATERA)

Which stock is Mark Massaro is most reserved on?

Potential downside of -$0 has been obtained for DNA (GINKGO BIOWORKS HOLDINGS)

What Year was the first public recommendation made by Mark Massaro?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?